APIC "How to do" Document: Interpretation of the ICH Q7 Guide
The API industry's practical interpretation of ICH Q7 — the "How to do" document of the Active Pharmaceutical Ingredients Committee (APIC), a Cefic sector group. Version 17, finalised in November 2024 and published as a free PDF, walks ICH Q7 section by section and describes how API manufacturers implement each requirement in practice. It is industry guidance, not law: like the IPEC excipient guide, its force comes from adoption, while the regulatory expectations remain those of ICH Q7 itself.
What this does not cover
stated in the document's own scope- Interprets ICH Q7 for active pharmaceutical ingredients; it is not itself a regulatory standard, and inspection findings cite Q7 and national GMP, never the "How to do" text.
- Covers APIs — excipient GMP is the IPEC-PQG guide's territory, and finished-product GMP belongs to the national GMP codes.
- An implementation aid: where its practical suggestions and a regulator's expectations diverge, the regulator's reading of Q7 prevails.
Always verify against the current published text before relying on it for a submission or inspection.
Overview
The APIC "How to do" document is the API industry's working interpretation of ICH Q7 — a section-by-section companion that takes the harmonised GMP guide for active pharmaceutical ingredients and describes how manufacturers implement each requirement in practice. Produced by the Active Pharmaceutical Ingredients Committee, a sector group of Cefic (the European Chemical Industry Council), it mirrors Q7's chapter structure — quality management, personnel, buildings and facilities, process equipment, documentation and records, materials management, production and in-process controls, laboratory controls, validation, change control, and the rest — and for each offers implementation approaches drawn from industry experience. Version 17 was finalised in November 2024 and, unusually for industry guidance, is published as a free PDF on apic.cefic.org.
Scope & applicability
Manufacturers of active pharmaceutical ingredients implementing ICH Q7. The document interprets; it does not replace — where the "How to do" text and ICH Q7 could be read differently, Q7 is the regulatory standard.
Legal basis & how it acquires force
Industry guidance with no legal force of its own: the regulatory standard is ICH Q7 as adopted in each jurisdiction (EU GMP Part II, FDA guidance, PIC/S adoption), and the "How to do" document interprets it. Where the interpretation and the guideline could be read differently, Q7 governs. Its authority is practical — a widely used consensus of API manufacturers on what good implementation looks like — in the same way the IPEC-PQG guide serves excipient GMP.
Document structure
| Part | Covers |
|---|---|
| Quality management and personnel | Implementing Q7's quality-unit responsibilities, documentation of duties, and training |
| Buildings, facilities and process equipment | Practical approaches to containment, utilities, cleaning, and equipment qualification in API plants |
| Documentation, materials and production | Records, materials management, in-process controls, and blending/recovery practice |
| Laboratory controls and validation | Specifications, stability, impurity profiling, and validation approaches for API processes |
| Change control, rejection, returns and complaints | Lifecycle controls from change management through complaint handling |
Key requirements
- Section-by-section implementation practice mirroring the ICH Q7 chapter structure
- Practical approaches for quality management, personnel, buildings, equipment, documentation, materials, production, laboratory controls, and validation in API plants
- Interpretations kept current with regulatory expectations through periodic revision (currently v17)
Implementation tips
- Use it as the drafting companion when writing API quality-system procedures against Q7 — it answers the "what does good look like" question Q7 deliberately leaves open, and it is free to distribute internally
Revision notes
Version 17 was finalised in November 2024 and published in early 2025 on apic.cefic.org, continuing a revision series maintained since ICH Q7's adoption.
Where this control fails
live FDA enforcementLive FDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.
International alignment
The document tracks ICH Q7 exactly — its structure is Q7's structure — and it complements the rest of the API compliance stack: EU GDP for active substances (2015/C 95/01) downstream, the IPEC-PQG guide next door for excipients (which exist precisely because Q7 covers actives, not excipients), and the ICH quality family (Q9 risk management, Q10 quality systems, Q11 development) that Q7 implementations draw on. APIC maintains companion documents on related API topics, revised on a continuing cycle.
APIC "How to do" ICH Q7 (v17): frequently asked questions
Quick answers to common questions about APIC "How to do" ICH Q7 (v17).
What is the APIC "How to do" document?
A free, section-by-section implementation companion to ICH Q7, written by the Active Pharmaceutical Ingredients Committee (a Cefic sector group). It describes how API manufacturers put each Q7 requirement into practice; version 17 was finalised in November 2024.
Is the APIC document legally binding?
No. It is industry guidance. The binding standard is ICH Q7 as adopted in each jurisdiction — EU GMP Part II in Europe, FDA's adopted guidance in the US, PIC/S adoption elsewhere — and the APIC text interprets that standard rather than adding to it.
Where can the document be obtained?
As a free PDF from apic.cefic.org — unlike most industry-body publications, it is openly published, which is one reason it circulates as the de facto implementation reference in API quality systems.
How does it relate to the IPEC-PQG excipient guide?
They are parallel solutions to adjacent gaps: ICH Q7 governs actives but not excipients, so the IPEC-PQG guide supplies excipient GMP, while the APIC document deepens the implementation of Q7 itself for API makers.
This standard in practice
Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.